CG
NVIV

Cutler Group’s InVivo Therapeutics Holdings Corp NVIV Stock Holding History

Cutler Group’s Portfolio NVIV Stock Details NVIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Hold
0
– -$1K – 7273
2017
Q2 		– Hold
0
– – – 6200
2017
Q1 		– Hold
0
– – – 4827
2016
Q3 		– Sell
-6
Closed -$11K – 7814
2016
Q2 		$11K Sell
6
-2
-25% -$235K ﹤0.01% 4080
2016
Q1 		$75K Buy
+8
New +$858K ﹤0.01% 1904

Other funds holding NVIV

ICM
IMS Capital Management Portland, Oregon $217M AUM 18.69% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $7.73B AUM 14.94% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

Cutler Group's NVIV Position: Q1 2018 in Review

Cutler Group held its InVivo Therapeutics Holdings Corp (NVIV) position steady in Q1 2018 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5789.

Cutler Group first reported a position in NVIV in Q2 2016 and has held it in 1 quarter since. The position peaked at $120K in Q2 2016. 25 funds tracked by Wall St. Rank hold NVIV as of Q1 2018.

  • Cutler Group held 0 shares of InVivo Therapeutics Holdings Corp worth $0 as of Q1 2018.
  • Cutler Group left its InVivo Therapeutics Holdings Corp share count unchanged in Q1 2018.
  • InVivo Therapeutics Holdings Corp made up ﹤0.01% of Cutler Group's portfolio in Q1 2018, its #5789 holding.
  • Cutler Group first reported a position in InVivo Therapeutics Holdings Corp in Q2 2016 and has held it in 1 quarter since.
  • Cutler Group's InVivo Therapeutics Holdings Corp position peaked at $120K in Q2 2016.
  • 25 funds tracked by Wall St. Rank held InVivo Therapeutics Holdings Corp as of Q1 2018.

Based on Cutler Group's 13F filing for Q1 2018, filed 11 May 2018.